Androgenic Alopecia. Androgenic alopecia, unspecified
Conditions
Interventions
The first group was treated with extra vesicles derived from umbilical cord blood serum with a selected concentration, the second group was treated with autologous PRP by injection, and the third grou
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Women and men with hereditary hormonal hair loss Age 18 years and above and less than 50 years The rate of hair loss in patients is Hamilton score 2 to 5 in men and Ludwig score 1 to 3 in women. Complete consent of the patient to participate in the study
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The number of hair follicles using the Trichoscan device, the thickness of the hair follicle using the Trichoscan device. Timepoint: Before the start of the intervention, each treatment session is monthly for 4 months and also 6 months after the end of the treatment. Method of measurement: Findings from VISIOFACE and TES-TB (low hair type with X1 lens, hair density and scalp condition with X60Triple lens, hair diameter and PORE condition with KPL X150 lens and hair shaft surface condition with X700 lens. | — |
Secondary
| Measure | Time frame |
|---|---|
| Safety and Efficacy. Timepoint: At the beginning of the intervention, monthly for 4 months, every one month, after 6 months. Method of measurement: Patient's history, examination, hair diameter, number of hair per surface unit, patient's satisfaction level. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactEhsan Taghiabadi
Tehran University of Medical Sciences
Outcome results
None listed